Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
DQ Huang, P Mathurin, H Cortez-Pinto… - Nature reviews …, 2023 - nature.com
Heavy alcohol consumption is a major cause of morbidity and mortality. Globally, alcohol per-
capita consumption rose from 5.5 litres in 2005 to 6.4 litres in 2016 and is projected to …
capita consumption rose from 5.5 litres in 2005 to 6.4 litres in 2016 and is projected to …
Health benefits and side effects of short-chain fatty acids
RG Xiong, DD Zhou, SX Wu, SY Huang, A Saimaiti… - Foods, 2022 - mdpi.com
The gut microbiota and their metabolites could play an important role in health and diseases
of human beings. Short-chain fatty acids (SCFAs) are mainly produced by gut microbiome …
of human beings. Short-chain fatty acids (SCFAs) are mainly produced by gut microbiome …
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
Liver cancer epidemiology is changing due to increasing alcohol consumption, rising
prevalence of obesity, and advances in hepatitis B virus (HBV) and hepatitis C virus (HCV) …
prevalence of obesity, and advances in hepatitis B virus (HBV) and hepatitis C virus (HCV) …
Microbiome-derived ethanol in nonalcoholic fatty liver disease
AS Meijnikman, M Davids, H Herrema, O Aydin… - Nature medicine, 2022 - nature.com
To test the hypothesis that the gut microbiota of individuals with nonalcoholic fatty liver
disease (NAFLD) produce enough ethanol to be a driving force in the development and …
disease (NAFLD) produce enough ethanol to be a driving force in the development and …
Changing epidemiology of hepatocellular carcinoma in Asia
C Zhang, Y Cheng, S Zhang, J Fan, Q Gao - Liver International, 2022 - Wiley Online Library
Liver cancer is the fifth most common cancer and the second leading cause of malignant
death in Asia, and Asia reports 72.5% of the world's cases in 2020. As the most common …
death in Asia, and Asia reports 72.5% of the world's cases in 2020. As the most common …
Hepatocellular carcinoma surveillance—Utilization, barriers and the impact of changing aetiology
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Gut microbiome, liver immunology, and liver diseases
R Wang, R Tang, B Li, X Ma, B Schnabl… - Cellular & molecular …, 2021 - nature.com
The gut microbiota is a complex and plastic consortium of microorganisms that are intricately
connected with human physiology. The liver is a central immunological organ that is …
connected with human physiology. The liver is a central immunological organ that is …
Alcohol-associated liver disease
B Mackowiak, Y Fu, L Maccioni… - The Journal of Clinical …, 2024 - Am Soc Clin Investig
Alcohol-associated liver disease (ALD) is a major cause of chronic liver disease worldwide,
and comprises a spectrum of several different disorders, including simple steatosis …
and comprises a spectrum of several different disorders, including simple steatosis …
[PDF][PDF] Diagnosis and treatment of alcohol‐associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases
DW Crabb, GY Im, G Szabo, JL Mellinger… - Hepatology, 2020 - Wiley Online Library
Alcohol-associated liver disease (ALD) represents a spectrum of liver injury resulting from
alcohol use, ranging from hepatic steatosis to more advanced forms including alcoholic …
alcohol use, ranging from hepatic steatosis to more advanced forms including alcoholic …
Noncancerous disease-targeting AIEgens
Y Duo, G Luo, W Zhang, R Wang, GG Xiao… - Chemical Society …, 2023 - pubs.rsc.org
Noncancerous diseases include a wide plethora of medical conditions beyond cancer and
are a major cause of mortality around the world. Despite progresses in clinical research …
are a major cause of mortality around the world. Despite progresses in clinical research …